Welcome
Support Centre
21 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Auto-titrating continuous positive airway pressure in patients with chronic heart failure and obstructive sleep apnoea
ISRCTN ISRCTN24943566
ClinicalTrials.gov identifier
Public title Auto-titrating continuous positive airway pressure in patients with chronic heart failure and obstructive sleep apnoea
Scientific title
Acronym N/A
Serial number at source PG/02/131/14612
Study hypothesis Auto-titrating Continuous Positive Airway Pressure (CPAP) improves subjective and objective measures of Chronic Heart Failure (CHF) severity in patients with CHF and Obstructive Sleep Apnoea (OSA).
Lay summary
Ethics approval The trial was approved by the Lothian Regional Ethics Committee (ref: LREC/2002/4/25) in 2002.
Study design Randomised double-blind placebo-controlled crossover trial
Countries of recruitment United Kingdom
Disease/condition/study domain Chronic heart failure and obstructive sleep apnoea
Participants - inclusion criteria 1. Stable symptomatic CHF (Left Ventricular Ejection Fraction [LVEF] less than 45%)
2. On optimal medical therapy with obstructive sleep apnoea (Apnea-Hypopnea Index [AHI] more than or equal to 15)
Participants - exclusion criteria 1. Acute coronary syndrome less than 3/12
2. Primary valvular heart disease
3. Sustained ventricular arrhythmias
4. Stroke with residual neurological deficit
Anticipated start date 01/07/2002
Anticipated end date 01/04/2005
Status of trial Completed
Patient information material
Target number of participants 30
Interventions Auto-titrating CPAP versus sham CPAP.
Primary outcome measure(s) Changes in peak maximal oxygen uptake (VO2) and six-minute walk distance.
Secondary outcome measure(s) Changes in:
1. LVEF
2. Minute ventilation versus carbon dioxide production (VE/VCO2) slope
3. Plasma neurohormonal makers
4. Quality of life
Sources of funding British Heart Foundation (UK) (ref: PG/02/131/14612, PG/02/078/14122)
Trial website
Publications Results in:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=17470670
Contact name Prof  David  Newby
  Address Centre for Cardiovascular Science
Chancellor's Building
49 Little France Crescent
  City/town Edinburgh
  Zip/Postcode EH16 4SB
  Country United Kingdom
Sponsor University of Edinburgh (UK)
  Address Old College
South Bridge
  City/town Edinburgh
  Zip/Postcode EH8 9YL
  Country United Kingdom
  Email communications.office@ed.ac.uk
  Sponsor website: http://www.ed.ac.uk/
Date applied 23/04/2006
Last edited 22/05/2007
Date ISRCTN assigned 20/11/2006
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central